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Abstract
Background: During evolution, innate immunity has been tuned to recognize pathogen-associated molecular patterns.
However, some a-Proteobacteria are stealthy intracellular pathogens not readily detected by this system. Brucella members
follow this strategy and are highly virulent, but other Brucellaceae like Ochrobactrum are rhizosphere inhabitants and only
opportunistic pathogens. To gain insight into the emergence of the stealthy strategy, we compared these two
phylogenetically close but biologically divergent bacteria.
Methodology/Principal Findings: In contrast to Brucella abortus, Ochrobactrum anthropi did not replicate within
professional and non-professional phagocytes and, whereas neutrophils had a limited action on B. abortus, they were
essential to control O. anthropi infections. O. anthropi triggered proinflammatory responses markedly lower than Salmonella
enterica but higher than B. abortus. In macrophages and dendritic cells, the corresponding lipopolysaccharides reproduced
these grades of activation, and binding of O. anthropi lipopolysaccharide to the TLR4 co-receptor MD-2 and NF-kB induction
laid between those of B. abortus and enteric bacteria lipopolysaccharides. These differences correlate with reported
variations in lipopolysaccharide core sugars, sensitivity to bactericidal peptides and outer membrane permeability.
Conclusions/Significance: The results suggest that Brucellaceae ancestors carried molecules not readily recognized by
innate immunity, so that non-drastic variations led to the emergence of stealthy intracellular parasites. They also suggest
that some critical envelope properties, like selective permeability, are profoundly altered upon modification of pathogen-
associated molecular patterns, and that this represents a further adaptation to the host. It is proposed that this adaptive
trend is relevant in other intracellular a-Proteobacteria like Bartonella, Rickettsia, Anaplasma, Ehrlichia and Wolbachia.
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Introduction
The class a-Proteobacteria includes microorganisms capable of
establishing close associations with eukaryotic cells in a wide range
of lifestyles. Members of the genus Agrobacterium are pericellular to
plant cells and induce tumors, whereas Brucella, Bartonella,
Phyllobacterium and Sinorhizobium are facultative extracellular-
intracellular bacteria that behave as pathogens or endosymbionts,
and Rickettsia, Anaplasma, Ehrlichia and Wolbachia are obligate
intracellular pathogens of mammals and arthropods [1,2].
Remarkably, animal pathogens of this group have the ability to
avoid immediate recognition by innate immunity, thus following a
stealthy strategy of which Brucella can be considered as a model [3].
In contrast, some bacteria close to Brucella are free living
environmental microorganisms like Ochrobactrum, Daeguia, Crab-
treella and Mycoplana. Although these four genera are included in
the Brucellaceae (http://www.bacterio.cict.fr/), only Ochrobactrum
has been reported to display some degree of pathogenicity.
Ochrobactrum anthropi, primarily a rhizosphere inhabitant, has been
isolated from immunocompromised individuals or patients
subjected to dialysis, catheterization, surgical interventions or
transplantation [4,5,6,7,8,9,10,11] and often shows a broad
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antibiotic resistance [12,13]. Ochrobactrum intermedium is another
opportunistic member of the genus. Interestingly, Ochrobactrum is
the Brucellaceae member closest to Brucella according to several
molecular markers and genome comparisons [14].
Owing to its close phylogenetic relatedness with the highly
virulent Brucella [15], Ochrobactrum has received some attention.
Phenotypic analysis reveals that O. anthropi displays envelope
molecules known to be critical in Brucella virulence. They include
phosphatidylcholine and a lipopolysaccharide (LPS) with a lipid A
carrying very long chain fatty acids (VLCFA). Also, like other
Brucellaceae, O. anthropi free lipids contain acyl chains with a higher
number of carbons than those found in typical Gram negative
bacteria. Along with the VLCFAs of lipid A, these structural
features are thought to be relevant in the construction of a firm
envelope which, in the case of Brucella, has been proposed to be
important in pathogenicity [16,17]. Despite these similarities,
there are differences in important outer membrane properties.
Most notably, while Brucella is highly permeable to hydrophobic
substances and resistant to bactericidal cationic peptides, Ochrobac-
trum is impermeable and sensitive, albeit not to the same extent as
typical Gram negative bacteria [18]. Interestingly, these differ-
ences have been correlated with some structural variations in the
LPSs of these bacteria [18]. LPS typically bears a marked
pathogen-associated molecular pattern (PAMP) and is thus a key
target of innate immunity [19]. Indeed, the altered PAMP of
Brucella LPS (BaLPS) greatly contributes to the stealthy strategy
and virulence of this pathogen [3,20]. All this evidence leads to the
hypothesis that the Brucellaceae ancestors carried such molecules
that without extensive remodeling resulted in features adequate to
evade innate immunity [3].
To examine this possibility, we compared O. anthropi with
Brucella abortus. We found that these bacteria display a significant
divergence in the interaction with host cells and the innate
immune system, and traced some of the differences to changes in
orthologs of key Brucella virulence determinants. The results not
only help to understand the widely different degrees of
pathogenicity of these bacteria but also how intracellular
pathogens following a stealthy strategy may have emerged in the
a-Proteobacteria.
Results
O. anthropi does not multiply intracellularly
We first compared the replication of O. anthropi and B. abortus in
mice after intraperitoneal injection, a route commonly used in
virulence studies [21]. As expected, B. abortus reached high
numbers one week after infection and maintained those numbers
throughout the experiment, reflecting the chronic nature of
brucellosis (Fig. 1A). O. anthropi, on the other hand, was recovered
in four orders of magnitude and CFU numbers diminished
throughout the experiment (Fig. 1A). However, under the
conditions used, clearance was not complete, indicating some
ability to persist. Although at 109 O. anthropi bacterial doses not
deaths were recorded, piloerection and diarrhea were observed at
48 h after infection, suggesting moderate endotoxicity.
We then studied the ability of O. anthropi to invade and multiply
in cells. For this, we first infected HeLa cells with O. anthropi or B.
abortus and killed extracellular bacteria with gentamicin. Even at
early times, O. anthropi was recovered in three orders of magnitude
less than B. abortus, thus showing its inability to induce
internalization (Fig. 1B). This was confirmed by intracellular-
extracellular differential fluorescence, which showed that less that
0.1% of HeLa cells interacted with O. anthropi and that most of the
visualized bacteria were located extracellularly. Moreover, where-
as the CFU numbers of intracellular B. abortus increased
throughout the experiment, those of O. anthropi declined steadily
(Fig. 1B). In order to bypass the internalization deficiency and to
determine if O. anthropi was able to multiply intracellularly, we used
the Escherichia coli Cytotoxic Necrotizing Factor, a toxin that
confers a phagocytic phenotype to HeLa cells [22]. This treatment
increased the intracellular O. anthropi in one order of magnitude
(Fig. 1B) and most visualized bacteria were intracellular.
Nevertheless, O. anthropi was not able to achieve sustained
replication, even though some survival was observed (Fig. 1B).
Then, we repeated the experiments in Raw 264.7 murine
macrophages. Although at early times the intracellular numbers
of O. anthropi paralleled those of B. abortus, the replication curves
coursed with opposite tendencies because, whereas B. abortus
replicated, O. anthropi did not (Fig. 1C). Noteworthy, the later
bacteria remained cultivable 48 h after infection (Fig. 1C).
Altogether, these results indicate that O. anthropi possesses a very
limited ability to invade and multiply intracellularly in cells.
O. anthropi expresses orthologs of Brucella virulence
determinants
We have shown that the cell envelopes of Brucella play a critical
role in virulence [23,24]. In part, this is due to some unusual
physicochemical properties linked to peculiar lipids (i.e. phospho-
lipids, ornithine lipids, LPS lipid A and lipoproteins) and to the
properties of the periplasmic cyclic b-glucans. Moreover, the
overall outer membrane protein profile [25] and some lipids [26]
(Conde-A´lvarez et al, unpublished) are under the control of the
BvrR/BvrS system, a critical Brucella virulence regulator. Also, the
envelope is the place where the type IV secretion system VirB is
expressed. To contrast these Brucella features with those of O.
anthropi, we first looked for the corresponding orthologs in genomic
databases. O. anthropi carried orthologs of Brucella genes known to
be involved in the synthesis of the periplasmic cyclic glucans,
ornithine lipids, and phosphatidylcholine. Flagellin genes (coding
for a PAMP-bearing protein) were present in O. anthropi and B.
abortus, even though both predicted proteins are modified in the
consensus sequence recognized by TLR5 [27]. In addition, B.
abortus lipoprotein genes omp19, omp16 and omp10 had orthologs in
O. anthropi. Other B. abortus putative lipoprotein ORFs were also
present in O. anthropi, although the one encoded by open reading
frame (ORF) BAB1_1548 carried a significant deletion encom-
passing 29 amino acids as compared to its ortholog. However, the
converse was not true since orthologs of the putative lipoproteins
corresponding to ORFs Oant_3560, Oant_1600, and Oant_2497
were not found in B. abortus (Table 1), suggesting a more simple
lipoprotein profile in the cell envelope of the latter bacteria.
Putative orthologous of genes coding for specialized acyltrans-
ferases and acylcarrier proteins (LpxXL and AcpXL) necessary to
synthesize and incorporate VLFACs to lipid A were also present.
We then examined the presence and expression of the two
component sensory-regulatory system BvrR/BvrS in O. anthropi.
The predicted proteins of the consecutive ORFs Oant_0827 and
Oant_0828 show 90.5% and 97.5% identity with BAB1_2092 (B.
abortus BvrR) and BAB1_2093 (B. abortus BvrS), respectively.
Primers designed on these sequences gave positive amplification
reactions from both O. anthropi genomic DNA and cDNA, thus
demonstrating transcription (Fig. 1D). In addition, an antibody
against B. abortus BvrR readily detected a single band in O. anthropi
lysates with a molecular weight consistent with that of the
predicted protein (Fig. 1D).
Finally, we searched for orthologs of the type IV secretion
system VirB. O. anthropi genome contains two DNA regions with
an organization and identity compatible with the presence of a virB
Bacterial Stealthy Pathogens
PLoS ONE | www.plosone.org 2 June 2009 | Volume 4 | Issue 6 | e5893
operon. The first one contains twelve consecutive ORFs (from
Oant_674 to Oant_685) with an organization similar to that of the
virB operon in B. abortus. With the exception of Oant_0679, which
encodes a hypothetical protein of unknown function, all other
ORFs have orthologs in the B. abortus virB operon, with percentage
identities between the homologous predicted proteins ranging
from 22.9% to 45.5%. In contrast, the second DNA region
contains only seven ORFs (Oant_4564 to Oant_4562, Oant_4559
to Oant_4557 and Oant_4555) and the predicted proteins show a
lower identity (from 18.1% to 35.1%) with the corresponding B.
abortus VirB products. Primers designed on the sequences of the
first DNA region for the virB4 (Oant_0677), virB5 (Oant_0678) and
virB8 (Oant_0682) orthologs gave a positive amplification from O.
anthropi genomic DNA and cDNA indicating their expression
(Fig. 1D). Moreover, while the BvrR orthologous protein strongly
reacted in Western blots, antibodies specific for B. abortus VirB8
showed only a weak band of the appropriate molecular weight in
O. anthropi lysates (Fig. 1D). These results demonstrate the closer
proximity between the BvrR/BvrS orthologs and indicate that in
the Brucellaceae there is higher degree of divergence in the type IV
secretion VirB systems committed to association with eukaryotic
cells than in the BvrR/BvrS systems devoted to cell envelope
homeostasis.
O. anthropi triggers leukocyte recruitment that lay
between those induced by B. abortus and S. enterica
The initial phases of B. abortus infection are characterized by a
negligible activation of proinflammatory mechanisms which
contrasts with those triggered by most Gram negative pathogens
[3]. We first tested to what extent this property was shared with O.
Figure 1. O. anthropi does not replicate in mice or in cells but expresses Brucella-associated virulence factors. (A) Groups of six mice
were inoculated intraperitoneally with 107 (white circles) or 109 (red circles) of O. anthropi or 106 of B. abortus (black circles) CFU/mouse. At the
indicated times the CFUs per spleen were calculated. (B) HeLa cells treated with CNF for 2 h or non-treated were infected with O. anthropi or B.
abortus at a MOI of 500. Extracellular bacteria were killed with gentamicin (100 mg/ml). At the indicated times intracellular CFU were determined. (C)
Raw 264.7 macrophages were infected with the indicated bacteria at a MOI of 500 and processed as in ‘‘B’’. (D) Lysates of O. anthropi (Oa) and B.
abortus (Ba) were probed with anti-VirB8 and anti-BvrR antibodies. Genomic DNA (1) or cDNA (2) from O. anthropi was used as template for PCR
amplification of the indicated genes. No amplification from total O. anthropi RNA preparation (minus RT) was observed (not shown). All values of O.
anthrophi in A, B and C were significantly different at p,0.001 with respect to B. abortus.
doi:10.1371/journal.pone.0005893.g001
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anthropi. As shown in Fig. 2A, O. anthropi induced recruitment of
leukocytes into the peritoneal cavity of mice, with more than a
twofold increase in 24 hours. The analysis of these leukocytes
indicated a rapid switch, with neutrophils increasing from 3% to
more than 40% at two hours after intraperitoneal inoculation
(Fig. 2B).
We also monitored the changes in blood after peritoneal
inoculation in comparison with B. abortus and S. enterica. Although
there was a quick initial decrease in the circulating leukocytes in
the three cases, numbers remained low in mice inoculated with S.
enterica. In contrast, there was a rapid return to basal levels in B.
abortus inoculated mice and an intermediate phenotype, slightly
closer to that of B. abortus, obtained with O. anthropi (Fig. 3A). The
evaluation of the blood leukocyte populations showed a moderate
change in the proportion of neutrophils in mice inoculated with B.
abortus (Fig. 3B) and a rapid increase of the same cells in mice
inoculated with S. enterica (Fig. 3C). Again, O. anthropi triggered an
intermediate response (Fig. 3D).
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Figure 2. O. anthropi recruits leukocytes in the peritoneum.
Groups of 6 mice were intraperitoneally inoculated with 106 CFU/ml of
O. anthropi. Thereafter, peritoneal exudates were obtained and
leukocytes counted. (A) Total number of peritoneum leukocytes (B)
Relative number of mononuclear (monocytes and lymphocytes) and
polymorphonuclear neutrophil leukocytes.
doi:10.1371/journal.pone.0005893.g002
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Neutrophils control O. anthropi but not B. abortus
infections
The above results indicated that O. anthropi induces a cellular
response compatible with acute bacterial infections and suggested
that neutrophils could play a protective role. In addition, we
previously observed that neutrophils do not play a significant role in
B. abortus infections in mice [3]. Thus, we evaluated the relevance of
these leukocytes in controlling O. anthropi using chronic neutropenic
mice. Forty-eight hours after infection, all the neutropenic but none
of the non-neutropenic mice were dead (Fig. 4A). The role of
neutrophils in controlling O. anthropi was confirmed by the results of
ex-vivo experiments with rat neutrophils (Fig. 4B).
O. anthropi activates complement through non-LPS
determinants
Both Brucella cells and LPS are very poor complement
activators [3]. To assess whether O. anthropi shares this property,
we incubated rabbit serum with B. abortus and O. anthropi and then
measured the lytic activity remaining in the supernatants using
antibody-sensitized erythrocytes. Whereas B. abortus practically
did not consume complement, O. anthropi completely abrogated
the lytic activity, demonstrating an effective surface binding and
the subsequent activation (Fig. 5A). Next, we tested the
bactericidal activity of bovine serum against these bacteria. In
agreement with the high avidity of the complement for the O.
anthropi surface, this bacterium was considerable more susceptible
to the bactericidal action of serum than B. abortus (Fig. 5B). Since
LPS is one of the main molecules responsible for complement
activation by Gram negative cell surfaces, we tested whether the
O. anthropi LPS (OaLPS) consumed complement. Surprisingly,
OaLPS was less effective than BaLPS in depleting complement
activity, even both were less effective than the LPS from S. enterica
(SeLPS) (Fig. 5C). Therefore, other O. anthropi surface molecules,
such as capsule polysaccharides, may be responsible for binding
complement.
Figure 3. O. anthropi infection induces an intermediate blood leukocyte response. Groups of 6 mice were inoculated intraperitoneally
with106 CFU/ml of the indicated bacteria, bleed at different times and leukocytes counted in blood. (A) Total leukocytes number of mice infected
with the indicated bacteria. (B) Relative blood leukocyte number of mice infected with B. abortus. (C) Relative blood leukocyte number of mice
infected with S. enterica. (D) Relative blood leukocyte number of mice infected with O. anthropi. Values of O. anthropi in ‘‘A’’ were significantly
different at p,0.01 (*) and p,0.001 (**) with respect to B. abortus. In ‘‘B, C and D’’ the standard error was less that 5% at all points.
doi:10.1371/journal.pone.0005893.g003
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O. anthropi and its LPS trigger cytokine responses that
lay between those of B. abortus and S. enterica
Proinflammatory cytokines, particularly TNF-a, increase
during acute Gram negative infections but not at the onset of
brucellosis. When we studied this in comparative terms, we found
that murine macrophages infected with O. anthropi released
significantly higher amounts of TNF-a than cells infected with B.
abortus (Fig. 6A), and this observation held true in vivo since mice
displayed higher TNF-a blood levels when inoculated with O.
anthropi than with B. abortus (Fig. 6B). O. anthropi, however, was not
as efficient as S. enterica in the induction of TNF-a release in vivo
(Fig. 6B).
Since LPS is the foremost PAMP-bearing molecule of Gram
negative bacteria, we compared the ability of OaLPS, BaLPS, and
E. coli LPS (EcLPS) to trigger cytokine responses in mice. OaLPS
consistently induced higher blood levels of TNF-a, IL-1 and IL-10
than BaLPS (Fig. 7A–C) but lower than those induced by EcLPS,
even if the latter was used at ten times less concentration (Fig. 7A–
C). Consistent with these results, OaLPS induced a higher cytokine
release in cultured macrophages than BaLPS (Fig. 7D insert). The
induction of TNF-a release by OaLPS was TLR4- but not TLR2-
dependent, because only macrophages derived from TLR4-
knockout mice failed to release this cytokine (Fig. 7D). This
pattern was similar to the induction of TNF-a by EcLPS, which
also depended on TLR4 and not on TLR2 (Fig. 7D). Under the
conditions used, the TNF-a levels produced by macrophages
stimulated with BaLPS were significantly lower in both TLR2- and
TLR4-deficient cells (Fig. 7D).
OaLPS partially induces dendritic cell maturation
Dendritic cells are key elements linking innate and adaptive
immunity. Since the evidence presented above situates the
induction of innate immunity by O. anthropi between those elicited
by enteric bacteria and B. abortus, we wanted to know whether this
was also true in these cells. To this purpose, we measured the ability
of the respective LPSs to trigger the formation of the dendritic cell
aggregosome-like induced structures (DALIS) characteristic of the
maturation of these cells. As expected, EcLPS induced more DALIS
than BaLPS. Moreover, in keeping with all the above-described
results, OaLPS displayed an activity that lay between BaLPS and
EcLPS (Fig. 8A). To confirm this, we measured the expression of
maturation markers in LPS-treated dendritic cells. As compared to
BaLPS, OaLPS induced a significantly higher expression of surface
CD40, CD80, CD86 and MHC-II which was, however, lower than
that triggered by EcLPS (Fig. 8B).
OaLPS partially activates NF-kB and its affinity for MD-2
lies between that of BaLPS and SeLPS
Most biological effects of LPS depend on its interaction with the
TLR4 co-receptor MD-2, an event that triggers a cascade of
signals leading to the NF-kB-dependent activation of immune
response genes. On the basis of the above-described results, we
hypothesized that OaLPS would have a higher binding to MD-2
than BaLPS but lower than SeLPS, and that this would lead to an
NF-kB activation between both types of LPSs. To test this
possibility, we compared first the ability of OaLPS, BaLPS, and
SeLPS to displace the hydrophobic probe bis-ANS from the
binding site of human MD-2 (hMD2) [28]. We found that SeLPS
was able to displace approximately 30% of bis-ANS from the
hMD-2-binding site at concentrations from 1.25–5 mg/ml
(Fig. 9A). Displacement by BaLPS, on the other hand, remained
close to the background values obtained with an equal amount of
water (Fig. 9A). At the highest concentration tested, OaLPS caused
a displacement similar to that induced by SeLPS. However, at
lower concentrations it approached the negligible values of BaLPS
(Fig. 9A). The interaction with hMD-2 was also measured as the
ability of the LPSs to block the recognition of hMD2 by anti-
hMD-2 monoclonal antibody (Fig. 9B). SeLPS inhibited this
antibody in a dose-dependent manner, with a 50% reduction in
the signal at a concentration of 2 mg/ml. BaLPS did not reduce
significantly the binding of the anti-hMD-2 antibody at any of the
concentrations tested. Again, OaLPS showed an activity that laid
between BaLPS and SeLPS since it blocked the antibody at
concentrations higher than those of SeLPS (Fig. 9B). Finally, we
Figure 4. Neutrophils are required for the control of O. anthropi
infections. (A) Neutrophils were depleted from twenty mice by
injection of the anti-neutrophil RB6 antibody and ten additional mice
were instead injected with PBS alone. One group of ten mice anti-
neutrophil treated and the group of ten mice injected with PBS alone
were then infected intraperitoneally with 109 CFU/mouse of O.
anthropi. The last group of ten mice treated with antibody anti-
neutrophil was inoculated with PBS alone. The lethality of the bacteria
was recorded at the indicated times. (B) O. anthropi was mixed with
purified rat neutrophils at a ratio of 564 bacteria/cell. Control bacteria
were not incubated with neutrophils. At the indicated times the viable
CFU were determined and the percentage of bacterial replication was
calculated. In ‘‘B’’ Values of p,0.01 (*) and p,0.001 (**) are indicated.
doi:10.1371/journal.pone.0005893.g004
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Figure 6. O. anthropi induces TNF-a that lays between B. abortus
and S. enterica. (A) Murine Raw 264.7 macrophages were infected for
30 min with O. anthropi or B. abortus at a MOI of 500. Extracellular
bacteria were killed by addition of gentamicin. At the indicated times
samples from the culture media were taken and processed for TNF-a
quantification. (B) Groups of 6 mice were inoculated intraperitoneally
with O. anthropi. At the indicated times mice were bled and TNF-a
levels were determined. The levels of TNF-a induction after 3 h of an
equivalent inoculation of B. abortus or S. enterica. Value of p,0.001 (**)
is indicated.
doi:10.1371/journal.pone.0005893.g006
Figure 5. O. anthropi cells but not its LPS fix complement. (A)
Rabbit serum was incubated with the indicated amounts of O. anthropi
or B. abortus cells. After incubation, the ability of the serum to lyze pre-
sensitized erythrocytes was determined and expressed as percentage of
hemolysis. (B) The indicated bacteria were incubated in the presence of
bovine serum for 90 min and their relative resistance was calculated.(C)
Rabbit serum was incubated with the indicated concentrations of
OaLPS, BaLPS or SeLPS. After incubation the ability of the serum to lyse
pre sensitized erythrocytes was determined. Values of O. anthropi in
were significant different at p,0.001 (**) with respect to B. abortus.
doi:10.1371/journal.pone.0005893.g005
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assessed the activation of the terminal end of the signaling pathway
by measuring the relative activity of a luciferase reporter under the
control of the NF-kB promoter in HEK 293 cells transfected with
expression vectors containing hMD-2, human TLR4 (hTLR4) and
human CD14 (hCD14). As can be seen in Fig. 9C, 10 to 25 times
higher concentrations of OaLPS were necessary to generate a
relative luciferase activity similar to that induced by 1 mg/ml of
SeLPS. Consistent with other observations, BaLPS induced a
weaker luciferase activity (Fig. 9C).
Discussion
We proposed that B. abortus follows a stealthy strategy which
relies on the absence, modification and inaccessibility of PAMP-
bearing molecules behind a firm outer membrane [3]. A related
hypothesis is that this pathogen has evolved from a free living a-
Proteobacteria bacterium with envelope structural features already
representing a first step towards innate immunity evasion
[3,18,29]. According to this, the Brucella ancestor underwent
further changes in such a structural scaffold upon contact with
innate immunity effectors and, in parallel, reduced its genome,
removed plasmids and trimmed-down its metabolic alternatives
[30]. The results presented here reinforce these hypotheses in
three ways: i), they show that the proinflammatory response to
Brucella is significantly lower than that to the closest known
neighbor bacteria which, significantly, is only an opportunistic
pathogen; ii) they demonstrate the existence of envelope molecules
prone to low recognition in Brucellaceae members that are primarily
Figure 7. OaLPS induces cytokine responses that lay between BaLPS. and SeLPS. (A, B and C) Groups of 6 mice were inoculated
intraperitoneally with BaLPS, EcLPS or OaLPS at the indicated concentrations. Mice were bled at 2 or 5 h and interleukins quantitated by ELISA. (D)
Bone marrow macrophages from wild type TLR22/2 and TLR42/2 knockout mice were incubated with the indicated LPSs. After incubation TNF-a
was quantified in the supernatant of cells at 24 h. The insert shows Raw 264.7 macrophages incubated with 25 mg of OaLPS or BaLPS and at the
indicated times TNF-a quantified from cell culture supernatants. Values of p,0.05 (*) and p,0.005 (**) with respect to BaLPS are indicated.
doi:10.1371/journal.pone.0005893.g007
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soil inhabitants and; iii) they support the notion that relatively few
and not drastic structural changes in a key PAMP-bearing
molecule result in very different lifestyles.
The early clinical evolution of human brucellosis is character-
ized by a negligible pro-inflammatory response [31], a phenom-
enon reproduced in experimental models [3]. In contrast, O.
anthropi infection triggered leukocytosis, neutrophilia, platelet
aggregation and acute fever [32,33], all indicative of sepsis. The
relevance of this response in O. anthropi infections is best
exemplified by the prominent role played by neutrophils. These
cells were bactericidal for O. anthropi and their absence converted
an otherwise harmless microbe into a lethal pathogen. This agrees
with the opportunistic character of O. anthropi and sets a clear cut
limit with brucellosis, where neutrophils do not seem to play a
Figure 8. OaLPS induces dendritic cell maturation that lay between BaLPS. and SeLPS. (A) BMDC were incubated with 0.1 mg of EcLPS,
10 mg of BaLPS or 10 mg of OaLPS in 1 ml culture and labeled with the anti-FK2 antibody for detection of DALIS at 24 h. The percentage of BMDC
positive for DALIS is indicated. (B) BMDC incubated as in ‘‘A’’ were labeled with fluorescent anti-CD40, CD-80, CD-86 and MHC II. Values of median
fluorescence correspond to four independent experiments. Values of p, 0.05 (*) and p,0.005 (**) with respect to BaLPS are indicated.
doi:10.1371/journal.pone.0005893.g008
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Figure 9. OaLPS shows an intermediate affinity for MD-2 and partially activates NF-kB. (A) Displacement of bis-ANS by LPS from the bis-
ANS/hMD2 complex. The bis-ANS/hMD2 complex (50 nM/50 nM) was incubated for 5 minutes to reach stable fluorescence (F0). Then, increasing
amounts of the indicated LPS or the same volume of water were added and fluorescence displacement measured. (B) Detection of free hMD2 by
ELISA after incubation (0.75 mM of hMD2) with increasing concentrations of the indicated LPS. (C) NF-kB expression measured by relative luciferase
activity of HEK293 transfected cells with hTLR4, hMD2, human CD14, NFkB-luc and Renilla containing plasmids upon respective LPS stimulation. The
responsiveness to LPS was determined by the NF-kB-responsive luciferase reporter plasmid, which was normalized using constitutively active Renilla
luciferase. Value of p,0.005 (**) with respect to BaLPS is indicated. In SeLPS all values beyond 0.1 mg were significant at p,0.005, with respect to
BaLPS.
doi:10.1371/journal.pone.0005893.g009
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significant role in controlling the infection [3]. It is tempting to
speculate that conserved molecules involved in Brucella virulence
like phosphatidylcholine, the VLCFA in lipoproteins and lipid A,
the periplasmic cyclic glucans, and the orthologous BvrR/BvrS
and VirB systems [34,35,36] participate in this survival. In the
natural environment of Ochrobactrum, these structures and systems
may be related to resistance to antibiotic peptides, osmotic stress,
the transference of plasmids, survival against protozoan predation,
or other modes of interaction with eukaryotic cells of the
rhizosphere [4,37].
Similarly to the proinflammatory response, It is striking that the
adaptive immune response provoked by O. anthropi also lies
between that induced by typical extracellular and intracellular
pathogens [38]. Indeed, while Brucella infection is characterized by
a protective Th1 immune response [39], O. anthropi infection
stimulates a mix of Th1 and Th2 type response which does not
protect against Brucella [38]. However, when switched to a Th1-
biased response by addition of the TLR9 agonist unmethylated
CpG, O. anthropi induces some protection against Brucella. Since
protection against Brucella is dependent on TLR9 and Myd88
[40,41] and, since unmethylated CpG is not accessible unless
envelopes are breached, then the toughness of the Brucella envelope
should play an important role in the stealthy behavior. The results
presented here and previously [18] evidences this and demon-
strates that O. anthropi differs from Brucella in crucial envelope
properties.
It is feasible to propose that Brucella ancestors had already
envelope molecules displaying determinants that departure from
the PAMPs targeted by innate immunity receptors. Since PAMPs
are conserved because they are functionally essential, one may ask
why this departure from the canonical structure was possible in the
Brucellaceae, and what kind of selective forces were behind it. In
most Proteobacteria, cell envelopes are impermeable to a large
variety of noxious substances through the combined action of
outer leaflet characteristics that do not allow the partition of
hydrophobic substances, a property linked to the high density of
negatively charged groups in the outer membrane [42,43]. This
leads to the conservation of those groups and, consequently, to
their ready recognition as PAMPs by innate immunity, as
illustrated by the wide array of bactericidal peptides that exert
their action upon binding to the negative charged groups in core
and lipid A.
Whereas O. anthropi keeps the permeability barrier, Brucella does
not and is concomitantly less sensitive to bactericidal peptides [18].
Significantly, this property also lays between the high resistance of
Brucella envelopes and the sensitivity of enterobacterial envelopes
to bactericidal cationic peptides [18]. This shows that Brucella and
O. anthropi represent a lineage endowed with outer membranes and
LPSs with some degree of resistance to bactericidal peptides and,
since the primary habitat of most Brucellaceae is the soil, it is likely
that this property resulted from the selective pressure of antibiotic
peptides produced by soil microorganisms. However, in Brucella
the permeability barrier to which sensitivity to bactericidal
peptides is linked, is no longer necessary to confront mucosal
surfaces or intracellular environments. Therefore, this property
could have been relinquished by the Brucella ancestor, keeping and
increasing its resistance to host bactericidal peptides.
An analysis of the respective LPSs, supports above developed
hypotheses (Fig. 10). The similarity of the biological activity of the
BaLPS and OaLPS makes unlikely that the respective O-chains
play a significant role since they are very different structures
[44,45] and, at least for B. abortus there is evidence for horizontal
acquisition [46]. On the other hand, the VLCFAs of both bacteria
represent a first departure of the canonical lipid A structure
(Fig. 10) that seems ancestral in a-2 Proteobacteria [47]. Since
VLCFAs carry an hydroxyl group at the iso position and are
postulated to span the outer membrane [47], they could provide a
firm anchorage that contributes to explain the integrity of the
outer membranes observed in the polymyxin B binding experi-
ments [18]. Detail core structures have not been elucidated for any
Brucella species or O. anthropi, but the available information on the
Brucella closer relative O. intermedium and on the sugar and lipid
compositions in B. abortus and O. anthropi also shows a departure
from enteric bacteria, with a comparatively lower number of
negatively charged groups (Fig. 10). Moreover, quantitative
analysis suggests a further charge reduction in Brucella LPS core
that is consistent with the loss of the permeability barrier and its
greater resistance to bactericidal peptides (Fig. 10).
The departure from the canonical PAMP in both the VLCFAs
of lipid A and in the negatively charged groups of the lipid A-core
of Ochrobactrum, enhanced further in B. abortus, is in agreement with
the results of the LPS-hMD-2 binding experiments. MD-2
comprises a hydrophobic pocket and some cationic domains that
correspond to two functional types of LPS recognition sites, one
for the lipid A portion and the other for the anionic groups
[28,48,49]. In the case of the lipid A, it would be impossible to
accommodate all acyl chains, particularly VLCFA, into the
hydrophobic pocket of MD-2. A model of TLR4 activation, that
suggests that the secondary acyl chain of the lipid A protrudes out
of the MD-2 pocket and directly interacts with hydrophobic side
chains of TLR4 (F440 and F463), diving the receptor dimerization
and activation, has been suggested [50]. In case of OaLPS we
propose that the VLCFA interact directly with TLR4, and in this
case the terminal hydroxyl group increases its propensity to be
exposed to the solvent. The key requirement for activation of
TLR4.MD-2 complex is the delivery of monomeric LPS, by LBP
and CD14, which may also be determined by the LPS core, which
differs between the Ochrobactrum and Brucella LPSs (Fig. 10). Since
these LPS structures are rooted in the phylogeny of the group, this
illustrates how relatively few structural changes on an orthologous
structure may contribute to adaptation to widely different
lifestyles.
Not all properties of O. anthropi were related to LPS. The
complete bacterium readily consumed complement and was killed
by serum, but its LPS did not trigger the lytic cascade.
Consequently, differences in other surface structures, such as O.
anthropi lipoproteins or extracellular polysaccharides [51], should
be responsible for complement activation and the ensuing
proinflammatory activities. Bacterial capsular polysaccharides
have been shown to consume complement and stimulate cytokine
production through TLR activation [52,53,54].
Animal pathogenic a-Proteobacteria have molecules not readily
recognized by innate immunity, and these bacteria also tend to
establish chronic infections [55,56,57,58,59]. For instance, Barton-
ella possesses a low agonist non-canonical lipid A with VLCFA, a
low number of lipoproteins and flagella not recognized by TLR5
[27,59,60]. In Rickettsia, there is an absence of flagella a reduced
number of lipoproteins and a non-canonical LPS [61,62]. The
insect Wolbachia parasites do not posses LPS, flagellum, fimbria or
pili, and contain a low number of lipoproteins and an unusual
peptidoglycan [63]. Intracellular Ehrlichia and Anaplasma have low
number of lipoproteins and do not have LPS, peptidoglycan or
flagellin [64,65]. Therefore it seems plausible that the a-
Proteobacteria intracellular pathogen ancestor may have been
endowed with structures prone to low recognition. In addition,
animals could have developed an innate immune repertoire that
preferably recognizes b and c-Proteobacteria rather than a-
Proteobacteria molecular patterns. In the case of Brucella, it is
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Figure 10. Model of Brucella, Ochrobactrum and Escherichia lipid As and core oligosaccharide moieties. [18,19,45]. The presence of three
KDO and phosphorylated heptoses confers five negative charges to the Escherichia coli core oligosaccharide. The core oligosaccharide of
Ochrobactrum LPS possesses galacturonic acid, in contrast to Brucella LPS core which does not possess this negatively charged acidic sugar. The
differential sensitivity of Escherichia, Ochrobactrum and Brucella to cationic peptides expressed as sensitivity to polymyxin B (PlxB) units (U) is linked to
the different LPSs properties such as uptake hydrophobic probes (NPN), PlxB binding, and LPS zeta potential (f) dependence after saturation with
polymyxin B [18]. Notice that upon saturation with PlxB, zeta potential became positive (1 mV) for Ochrobactrum LPS while remaining negative
(25 mV) for Brucella smooth LPS, suggesting hindered access to inner targets. Ochrobactrum and Brucella LPSs does not show significant differences
in lipid A structure and acyl chain fluidity and display very similar structure [18,19,45]. It has been proposed that the quinovosamine sugar in
Ochrobactrum and Brucella LPS links the O core oligosaccharide with the O-chain polysaccharide [21].
doi:10.1371/journal.pone.0005893.g010
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possible that evolutionary pressures linked to innate immunity
forced for the selection of organisms displaying low PAMPs
recognition [66]. The selective forces working in the second
scenario could be linked to the early endosymbiotic relationship
between eukaryotic cells and a-Proteobacteria ancestors [67] which
would have led to the identification of some bacterial molecules as
‘‘self’’ in relation to those of b and c-Proteobacteria, which appeared
later in evolution [68]. It is worth noting, however, that all these a-
Proteobacteria have orthologous type IV secretion systems, which
seem to be essential for controlling the intracellular survival.
We propose that, Brucella evolved from an opportunistic
pathogen, non markedly endotoxic ancestor within a mammal
environment [30,69] by: i), removing microbial molecular
determinants such as capsules and fimbriae; ii), modifying surface
molecules such as flagella, lipoproteins and LPS to provide high
resistance to bactericidal cationic substances and complement and,
concomitantly, avoid recognition by TLRs; iii), keeping structures
such as peptidoglycan and unmethylated DNA under a tough
envelope; and iv), maintaining the regulatory systems (e.g. BvrR-
BvrS) that control the homeostasis of an outer membrane whose
overall structure is essential in the interaction with the host. This
furtive strategy, which also required a remodeling of ancestral type
IV secretion systems to sneak and reproduce in cells, does not
preclude the development of determinants actively hampering the
activation of immunity at later stages [70,71,72].
Finally, the recorded phenotypic, biological and pathogenic
differences between Brucella and Ochrobactrum, strengthens argu-
ments for maintaining these two bacterial clusters as separate
genera in the Brucellaceae and reinforce the concept that non-drastic
molecular variations generate marked divergences that result in
different biological groups.
Materials and Methods
Ethics Statement
All animals were handled and sacrificed according to the
approval and guidelines established by the ‘‘Comite´ Institucional
para el Cuido y Uso de los Animales of the Universidad de Costa
Rica’’, and in agreement with the corresponding law ‘‘Ley de
Bienestar de los Animales No 7451’’ of Costa Rica (http://www.
protecnet. go.cr/salud). The recommendations stated in the
Weatherall report ‘‘The use of non-human primates in research’’
(http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d
=MRC003440), were followed accordingly.
Bacterial strains, LPSs and biological reagents
Salmonella enterica sv. typhimurium strain SL1344, virulent B. abortus
2308, and O. anthropi LMG 3331T have been previously described
[1,45,73]. BaLPS, OaLPS, SeLPS and EcLPS were purified and
characterized as previously described [18,24]. S. enterica
(strainHL83) LPS was provided by K. Brandenburg (Forschungs-
zentrum Borstel, Germany). E. coli CNF was purified as previously
described [22]. BvrR was cloned as glutathione-S-transferase
(GST) fusion protein in pGEX-2TK vector, expressed in E. coli
BL21(DE3), and purified following standard protocols. Rabbit
anti-BvrR antibodies were produced by four intramuscularly
applied boosts of GST-BvrR (250 mg) in complete (first boost) or
incomplete (second to fourth boost) Freund adjuvant (Sigma-
Aldrich Co.). Antibodies from 2 ml of serum were adsorbed to
GST-BvrR-Sepharose beads, eluted with 0.2 M glycine, pH 2.5,
and collected in 1 M Tris, pH 9,0. The antibodies were
concentrated by ultrafiltration and stored at -20uC in 50%
glycerol. The anti-Ochrobactrum antibody was produced in a rabbit
by 4 boosts of intramuscular injections of formaldehyde fixed
bacteria. The specificity of the antibody was confirmed by
immunofluorescence against a panel of related a-Proteobacteria.
Enzyme linked immunosorbent assay (ELISA) kits for cytokine
determination were from BD Biosciences (San Diego, CA.).
Monoclonal antibody RB6-8C5 against murine granulocytes was a
gift from Ba¨rbel Raupach, MPIIB, Berlin, Germany. Allophyco-
cyanin conjugated-anti-CD11c antibody (HL3) and phycoery-
thrin-conjugated anti-CD40, -CD80, -CD86, and -MHC class II
were all from Pharmingen. Mouse antibody FK2 (Biomol) was
provided by D. Williams (University of Toronto). The properties
and reactivity of anti-VirB8 antibody have been described before
[74].
Infections and bacterial counts in experimental animals
The characteristics, source and maintenance of Balb/c,
C57BL/6 and the KO counterparts TLR42/2 and TLR22/
2, mice have been described previously [3,72]. Generation of
neutropenic mice was performed as described before [3]. For
calculating the bacterial multiplication rates in spleens, groups of
20 eight-week-old female BALB/c were intraperitoneally inocu-
lated with 0.1 ml of a suspension of the indicated bacteria species.
Animals for each group were killed by cervical dislocation at
appropriate times. Spleens were aseptically removed and individ-
ually homogenized in 1 ml PBS. Dilutions from this homogenate
were seeded on TSA and CFU numbers determined. Alternatively
mice were inoculated with 0.1 ml (pyrogen-free sterile PBS) of the
indicated LPS preparation by the intraperitoneal route. Wistar rats
were maintained in the animal facility of the Veterinary School of
the National University, Costa Rica. Cytokine or leukocyte counts
were performed in the peritoneum and blood of infected or LPS
inoculated mice as described previously [3].
Infections and bacterial counts in macrophages and
epithelial cells
Human cervix carcinoma cells (HeLa; American Type Culture
Collection No. CCL-2) were grown at 37uC under 5% CO2 in
Eagle’s minimal essential medium supplemented with 5% fetal
bovine serum, 2.5% sodium bicarbonate and 1% glutamine (all
from Gibco, Inc.). Murine macrophages (Raw 264.7; American
Type Culture Collection No. TIB-71) were grown at 37uC under
5% CO2 in Dulbecco’s medium supplemented with 10% fetal
bovine serum, 2.5% sodium bicarbonate and 1% glutamine (all
from Gibco). Penicillin (100 units/ml) and streptomycin (100 mg/
ml) routinely added, were excluded from cell cultures during
Ochrobactrum and Brucella infections. Before infection, 24-well-plates
monolayers were washed in PBS and kept at 4uC. Infections were
carried out using cultures of O. anthropi or B. abortus in logarithmic
phase diluted in Eagle’s minimal essential medium to reach the
desired multiplicities of infection (MOI). Plates were centrifuged at
3006g at 4uC, incubated for 30 min at 37uC under 5% CO2 and
washed 3 times with PBS. Extracellular bacteria were killed by
adding Eagle’s minimal essential medium supplemented with
100 mg/ml gentamicin for 1 h for B. abortus or 4 h for O. anthropi.
Cells were further incubated for the indicated times in the
presence of 5 mg/ml gentamicin for B. abortus or 100 mg/ml
gentamicin for O. anthropi. Plates were then washed with PBS. Cells
were lyzed with 0.1% Triton X-100 for 10 min. Aliquots were
diluted and plated in tryptic soy agar and incubated at 37uC for
determination of CFU. For immunofluorescence experiments
HeLa cells or Raw 264.7 macrophages grown on 12 mm glass
slides were inoculated with B. abortus or O. anthropi as described
above and kept in the presence of gentamicin for the indicated
times. After incubation cells were fixed with 3.7% paraformalde-
hyde-PBS and free aldehyde groups were quenched with 50 mM
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NH4Cl-PBS. After permeabilization with 0.5% Triton-PBS, total
bacteria were labeled with rabbit anti-Ochrobactrum antibodies
followed by TRITC conjugated anti-rabbit antibodies.
Confocal microscopy and flow cytometry of LPS treated
dendritic cells
Immunofluorescence confocal microscopy and flow cytometry
of LPS treated murine bone marrow derived dendritic cells
(BMDC) were performed as described before [72]. Briefly,
paraformaldehyde fixed cells processed by immunofluorescence
were examined on a Zeiss LSM 510 laser scanning confocal
microscope for image acquisition. Antibody against a conserved
cytoplasmic epitope found on MHC-II I-Ab which strongly labels
BMDC but not macrophages was used throughout the experi-
ments. For confirmation of the dendritic cell phenotype, double
labeling with anti- MHC-II and anti-CD11c antibody was
performed. Quantification was always done by counting at least
100 cells in 4 independent experiments, for a total of at least 400
host cells analyzed. DALIS BMDC were collected and stained
immediately before fixation. Isotype controls were included as well
as BMDC non-LPS treated as control for autofluorescence. Cells
were always gated on CD11c for analysis and at least 100000
events were collected to obtain a minimum of 10000 CD11c
positive events for analysis. A FACS calibur cytometer (Becton
Dickinson) was used and data was analyzed using FlowJo software
(Tree Star).
Electrophoretic and immunochemical analysis
The different bacterial strains were grown to exponential phase
in TSB at 37uC. The bacteria were concentrated by centrifugation
(100006g, 10 min), resuspended in Laemmli sample buffer [75]
and heated at 100uC for 20 min. Protein concentration was
determined by BioRad DC method according to the manufactur-
er’s instructions and equal amounts of protein (20 mg) were loaded
onto a 12.5% gel for SDS-PAGE. Separated proteins were
transferred to PVDF membrane and probed with the indicated
antibodies. Membranes were further incubated with peroxidase
conjugated anti-mouse or anti-rabbit antibodies and the detected
bands were visualized by chemiluminescence reaction exposed to
X-ray films.
PCR and RT-PCR
Genomic DNA was isolated by CTAB method according to
standard procedures [76]. Specific amplification from gDNA or
cDNA was achieved with the following primers designed after
analysis of O. anthropi genome: for locus Oant_0677: oantvirB4f
GGATTACACCGTGACCTCAAC and oantvirB4r GCCTGA-
TAACATGCGTCCATAA; for locus Oant_0678: oantvirB5.3
CGATGCTCTTCATCAGCAGATTGAG, oantvirB5.5 CTTT-
GCGACATCCGCCATATC; for locus Oant_0682: oantvirB8.3
GATCAAGACCGCATGATTCAGG, oantvirB8.5 GTCACG-
GCTTCGTCGTAAGTG. For amplification of gDNA or cDNA
encoding putative bvrR and bvrS, the following primers were used:
for Oant_0827 (bvrS): oantbvrS.3 GCATTCTCTACATGAAT-
CAGTTCC and oantbvrS.5 GTGATGGCGTCAGGCTTTG.
And for Oant_0828 (bvrR): oantbvrR.3 GACGACGACCGCAA-
CATCCTG and oantbvrR.5 CGAAGATCGCAAGATTGGGC.
Positive controls of amplification of genomic DNA or cDNA were
achieved using a pair of primers oantl12.3 CTGTCGGCACT-
GACCGTTCTCG and oantl12.5 CGCCACCAGCAGCAG-
CAACTG interrogating locus Oant_1946, encoding the ribosomal
protein L7/L12. Cycling conditions were: 94uC for 4 min, 30
cycles at 94uC for 30 s, 50 or 65uC for 1 minute and 68uC for 30
seconds and continued with a 68uC incubation for 10 minutes.
The PCR products were analyzed on agarose gels using standard
procedures. For RNA extraction bacterial cultures were adjusted
to 109 CFU/ml and disrupted with 0.5% Zwittergent 3–16 at
37uC for 1 h. Total RNA was extracted using RNeasy Midi Kit
(Qiagen, Co.) according to the manufacturer’s instructions. Eluted
RNA was treated with Ambion Turbo DNAse following the robust
protocol. Synthesis of cDNA was carried out using Revert Aid M-
MuLV Reverse Transcriptase with random hexamers and
following manufacturers’ Instructions. (Fermentas). The obtained
cDNA was used as template for detection of the genes mentioned
above by PCR using the same primers described. Minus RT
controls were performed using RNA samples during PCR.
Complement depletion and bactericidal action of serum
Complement consumption was estimated as previously de-
scribed [77,78]. Briefly, rabbit serum was incubated with live
packed bacteria or LPS for 30 min at 37uC. After incubation, the
complement activity on the serum was detected as the ability to
lyze sheep erythrocytes pre-sensitized with guinea pig anti-sheep
antibodies. For the estimation of complement bactericidal activity,
exponentially growing bacteria were adjusted to 104 CFU/ml in
saline and dispensed in triplicate in microtiter plates (45 ml per
well) containing fresh normal bovine serum (90 ml/well). After
90 min of incubation at 37uC, brain heart infusion broth was
dispensed (200 ml/well), mixed with the bacterial suspension and
100 ml was plated on TSA. Results were expressed as the
percentage of CFU with respect to the inoculums in three assays.
Binding of LPS to hTLR4 co-receptor hMD-2 protein
Binding of LPS to MD-2 was assayed by two different methods:
displacement of bis-ANS from hMD-2 by LPS, and binding to
hMD-2 by competitive enzyme linked-immunosorbent assay
(ELISA). Recombinant hMD-2 was produced in E. coli and
isolated as described before [79]. In both assays, LPS was
subjected to three cycles of heating at 56uC followed by cooling to
4uC, left over night and sonicated before using. Binding of bis-
ANS to hMD-2 was measured at 20uC using excitation at 385 nm
and measuring the emission fluorescence spectra between 420 and
550 nm. Then, from 5 to 80 ml of a LPS stock at 0.125 mg/ml was
added (controls were prepared with the same volume of water) to
preincubated bis-ANS/hMD-2 complex (50 nM/50 nM). The F0
value was the fluorescence of bis-ANS/hMD-2 complexes after
5 min of incubation (to reach stable fluorescence).The FLPS value
was the fluorescence after LPS addition to the complex.
Fluorescence was measured on Perkin Elmer fluorimeter LS 55.
Quartz glass cuvettes (565 and 1065 mm optical path, Hellma
Suprasil) were used and bis-ANS was obtained from Sigma (St.
Louis, Missouri, U.S.A.). The ELISA for determination of LPS
binding to hMD-2 was performed in 96-well plates (NUNC
immunoplate F96 cert. Maxi-sorp, Roskilde, Denmark). Chicken
polyclonal anti-hMD-2 (GenTel, Madison, WI, U.S.A) (5 mg/ml)
in 50 mM Na2CO3 (pH 9.6) was used to coat the microtiter plate
at 4uC overnight. Excess binding sites were blocked with 1% BSA
in PBS buffer (pH 7.2) for 1 h at room temperature, and rinsed
three times with the same buffer. During the blocking step, hMD-2
(0.75 mM) was preincubated with 0 mg/ml to 20 mg/ml LPS at
37uC and, as a negative control, LPS was also preincubated in
absence of hMD-2. These solutions were added to the plate, which
was then incubated for 1 h at 37uC. After rinsing, only hMD-2
without LPS was detected by incubation with 0.1 mg/ml of mouse
monoclonal anti-hMD-2 (clone 9B4 e-Bioscience San Diego, CA.,
U.S.A.) in PBS buffer at 37uC for 1 h, followed by incubation with
0.1 mg/ml peroxidase-conjugated goat anti-mouse IgG (Santa
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Cruz, CA., U.S.A.), also in PBS buffer at 37uC for 1 h. After plate
washing, ABTS (Sigma) was added, the reaction was stopped with
1% SDS after 15 min, and the absorbance at 420 nm measured
using a Mithras LB940 apparatus. (Berthold Technologies). S.
enterica (strainHL83) LPS, used as a control.
Stimulation of NF-kB transcription by purified LPS. HEK293
cells (ATCC CRL-1573) were transiently transfected with 3 ng
hTLR4, 6 ng hMD-2, 5 ng hCD14 expression vectors, 50 ng of
NF-kB or IP-10 promoter dependent luciferase reporter, and 5 ng
constitutive Renilla reporter plasmids, using lipofectamine 2000
(Invitrogen). After 6 h, media were changed to Dulbeccos’s
modified Eagle’s medium supplemented with 10% fetal bovine
serum and different amounts of LPS were added to the cells. As a
negative control, we used cells transfected with the same plasmids
but without addition of LPS. After 20 h, cells were lyzed and
analyzed for reporter gene activities using a dual luciferase
reporter assay system on a Mithras LB940 apparatus (Berthold
Technologies). The data of luciferase activity were normalized
using Renilla luciferase readings.
Statistical methods
Student’s t test for was used for determining the statistical
significance in the different assays. For bacterial colonization
experiments, the Mann-Whitney test was performed accordingly
(http://faculty.vassar.edu/lowry/utest.html).
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